Interested in using Causomic? We’re partnering with a small number of teams to validate our NSCLC trial simulation model.
Bring your compound and relevant clinical data.
Simulate your trial across thousands of virtual patients.
Explore different trial designs and identify the most promising approach.
Bring the compound and what is known about it — mechanism of action, preclinical data, Phase I PK/PD, the indication. What comes back is a model of that compound: it has to reproduce what has already been observed before it is allowed to project anything. Every virtual patient below is dosed with it.
Illustrative calibration on simulated data.
Simulate each protocol across thousands of virtual patients, varying eligibility criteria, biomarkers and patient characteristics to understand how each design performs across realistic populations.
Illustrative NSCLC cohort. These are simulation outputs, not results from a clinical trial.
Explore and compare thousands of possible Phase II designs across the same virtual population, before enrolling a single patient.